RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression
Journal of Clinical Investigation · 16.06.2025 · 135 (12)
DOI: 10.1172/jci185119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.06.2025. Verfasst von Miyeong Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Cancer Biology. Hauptthemen laut MEDLINE: E2F1 Transcription Factor, Ribosomal Protein S6 Kinases, 90-kDa, Tripartite Motif-Containing Protein 28, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH.
Abstract (Originalsprache)
Castration-resistant prostate cancer (CRPC) marks the advanced and lethal stage of prostate cancer (PCa). TRIM28, also known as KAP1, is a transcriptional regulator recently shown to promote CRPC cell proliferation and xenograft tumor growth. Nonetheless, knowledge gaps persist regarding the mechanisms underlying TRIM28 upregulation in CRPC as well as the genomic targets regulated by TRIM28. Here, we report that TRIM28 is a E2F1 target in CRPC. Using an integrated genomic approach, we have demonstrated that TRIM28 forms a positive feedback loop to promote the transcriptional activation and genomic function of E2F1 independent of retinoblastoma (Rb) status. Furthermore, we identified RSK1 as a kinase that directly phosphorylates TRIM28 at S473, and, as such, RSK1 drives the TRIM28/E2F1 feedback loop. Accordingly, pS473-TRIM28 promotes CRPC progression, which is mitigated by RSK inhibition. In summary, our study reveals a critical role of the RSK1–TRIM28–E2F1 axis in CRPC progression, which may be exploited as a vulnerability in treating Rb-deficient CRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology and Cancer Biology.
- Department of Biostatistics, College of Public Health.
- Department of Pathology & Laboratory Medicine.
- Department of Molecular and Cellular Biochemistry, and.
- Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIH
- V Foundation for Cancer Research
- American Cancer Society
- national institute of health
Zitieren
APA
Kim, M., Liu, J., Zhang, Y., Wang, R., Goettl, R., Grasso, J., Allison, D. B., Wang, C., Gao, T., Liu, X., & Fong, K. W. (2025). RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression. Journal of Clinical Investigation, 135(12). https://doi.org/10.1172/jci185119
Vancouver
Kim M, Liu J, Zhang Y, Wang R, Goettl R, Grasso J, et al. RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression. Journal of Clinical Investigation. 2025;135(12). doi:10.1172/jci185119
BibTeX
@article{Kim2025,
author = {Kim, Miyeong and Liu, Jinpeng and Zhang, Yanquan and Wang, Ruixin and Goettl, Ryan and Grasso, Jennifer and Allison, Derek B and Wang, Chi and Gao, Tianyan and Liu, Xiaoqi and Fong, Ka-Wing},
title = {RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {12},
doi = {10.1172/jci185119}
}
EUVIMED